Speaker
Description
GANIL has been celebrating the 40th anniversary of the first experiment that ran in 1983 with an 40Ar beam accelerated with two cyclotrons at the energy of 44 MeV per nucleon. Since this first exciting period, GANIL has undergone a continuous evolution and some major upgrades, guided by the needs expressed by users, to remain at the forefront of research in accelerator-based science.
The abundances of elements observed on earth or in space is the result of a large number of processes driven by the fundamental interactions and properties that bind the constituents of the atomic nucleus. Some of these nuclear processes are reproduced on earth, not only at accelerators such as GANIL, but also in the nuclear industry, whether for energy or medical purposes. In this respect, GANIL can make important contributions to improving the knowledge needed for sustainable development or improving safety margins in the field of nuclear data of interest for energy or health applications, in particular the production of innovative radio-isotopes for nuclear medicine.
The study of radiation on living organisms is part of the development of new cancer therapy techniques. The instrumentation developed at GANIL offers modern dosimetry techniques for hadrontherapy. Last but not least, the study of the effects of radiation on the behavior of matter enables us to investigate new materials and more durable electronic components for nuclear and space industries.
Present activities and projects for developing the applications of GANIL activities will be discussed.
